Used as main image by Phynd in search results and profile page

Scott J Cotler, MD

Gastroenterology, Internal Medicine, Transplant Hepatology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

855-483-7362
Appointments (New Patients Welcome)
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
855-483-7362

Services & Specialties

Areas of Specialization

  • Gastroenterology
  • Internal Medicine
  • Transplant Hepatology

Locations & Contact

Primary Location

Loyola Hepatology Peoria

Carle Health Methodist - Atrium Medical Office Center, 900 Main Street
Suite 100
Peoria , IL 61602

View hours
Monday
12:00am - 12:00am
Tuesday
12:00am - 12:00am
Wednesday
12:00am - 12:00am
Thursday
12:00am - 12:00am
Friday
12:00am - 12:00am
Saturday
12:00am - 12:00am
Sunday
12:00am - 12:00am
Loyola Hepatology Peoria

Loyola Medicine Burr Ridge

6800 N Frontage Rd
Burr Ridge , IL 60527

Loyola Medicine Burr Ridge

Loyola Outpatient Center

2160 S First Ave
Maywood , IL 60153

Loyola Outpatient Center

Loyola Hepatology Clinic Rockford

2902 McFarland Rd
Ste 202
Rockford , IL 61107

Loyola Hepatology Clinic Joliet

301 N Madison St
Medical Office Bldg - Suite 307
Joliet , IL 60435

Loyola Hepatology Clinic Moline

545 Valley View Dr
Moline , IL 61265

View hours
Monday
12:00am - 12:00am
Tuesday
12:00am - 12:00am
Wednesday
12:00am - 12:00am
Thursday
12:00am - 12:00am
Friday
12:00am - 12:00am
Saturday
12:00am - 12:00am
Sunday
12:00am - 12:00am
Loyola Hepatology Clinic Moline

Loyola Hepatology Clinic Naperville

Edward Heart Hospital - 801 S. Washington St
4th Floor
Naperville , IL 60540

Loyola Hepatology Clinic Peru

1310 Maple Dr
Peru , IL 61354

View hours
Monday
12:00am - 12:00am
Tuesday
12:00am - 12:00am
Wednesday
12:00am - 12:00am
Thursday
12:00am - 12:00am
Friday
12:00am - 12:00am
Saturday
12:00am - 12:00am
Sunday
12:00am - 12:00am
Loyola Hepatology Clinic Peru

Loyola Hepatology Mendota

1401 E 12th St
Community Health Services Room
Mendota , IL 61342

About

Academic Title

Professor

Leadership Title

FCO Division Director, Hepatology

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Board Certifications

Gastroenterology, Gastroenterology, American Board of Internal Medicine Subspecialty (1995)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(261 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

74 Reviews

09/13/2024

Very pleased with Dr. Cotler.

09/10/2024

Speak to me in terms i can understand

08/16/2024

All good care received.

08/13/2024

Doctors appear to be very rushed these days … need to move on to next patient. Don’t feel they spend as much time as necessary with ME as they used to.

08/06/2024

Seems concerned

08/05/2024

I trust Dr. Cotler with my health care.

07/29/2024

Good

07/22/2024

I would highly recommend Dr. Cotler and his team for anyone needing a specialist in his area of expertise.

07/11/2024

He is very concerned about me as a patient. Always makes sure that i do or don't have any concerns or questions.

06/28/2024

I have only seen him once and for 15 minutes. Can’t judge

06/24/2024

Everything was good

06/24/2024

Genuine and gave great advice

06/13/2024

Very good

06/10/2024

A wonderful to stude ts and reside ts on how to interact with patoents and families

06/04/2024

The staff are very friendly and make you feel comfortable

05/09/2024

I would easily and confidently recommend him.

05/07/2024

None better than Dr Cotler and Ivanna!

04/19/2024

Dr. Always looks out for your needs.

04/15/2024

Trusting kind knowledgeable excellent

04/15/2024

Muy buena atención

04/11/2024

good

04/09/2024

Dr. Cotler was so caring and understanding which made my visit very comfortable

04/01/2024

Dr. Cotler is a new doctor for me and I was very pleased! Makes me feel comfortable

03/26/2024

Muy bueno todo en general. No me arrepiento de haber ido por primera vez.

03/20/2024

Eased my mind

03/20/2024

Dr Cotler was very pleasant and he took time with me and my husband answering questions we had.

03/14/2024

As mentioned, Dr. Cotler is kind and caring.

03/12/2024

Every good

02/27/2024

Very concerned, courteous, and informative.

02/26/2024

being my first visit with Dr. Cotler was treated with respect

02/20/2024

Resident was gracious and courtesy.

02/16/2024

Great experience.

02/13/2024

so caring and never rushes me out the door !

02/13/2024

Love Dr. Cotler

02/12/2024

The doctor has excellent bedside manner.

02/06/2024

His Nurse Ivanka is excellent at scheduling future tests and appointments . She has a caring and compassionate manner.

02/02/2024

Very happy with my overall experience!

01/19/2024

I am grateful for Dr. Cutler

01/19/2024

awesomesauce

01/16/2024

Excellent

01/12/2024

I was extremely pleased with my care.

01/11/2024

Dr. Cotler was the first of my dr.s to not just see on a chart saying that I had Cirrhosis and assume it was correct. He has also been 100% sure in curing my hepatitis C.

01/08/2024

Dr. Cotler is someone I trust.

01/05/2024

Dr. Cotler took time and explained everything throughly.

01/02/2024

Dr Cotler and Ivanna are a great team. They also interfaced with my other specialists to ensure Coordinated care.

12/06/2023

I'm very happy with Dr. Cotler and staff

11/29/2023

Very confident

11/28/2023

Tests were ordered and the results were monitored/ Excellent feedback, High recommend his service to others.

11/27/2023

Dr Scott Cotler is very professional and cares about his patients. He is the only reason I still go to Trinity Loyola

11/21/2023

I feel fortunate to have Dr Cotler

11/21/2023

I see Dr Cotler twice a year and the experience is always good

11/17/2023

Dr Colter and the Intern made me feel very comfortable and give outstanding care. Very detailed in everything. Easy to understand and they care about the patients.

11/16/2023

First visit, staff very friendly and professional, communication was great

11/16/2023

Would highly recommend this facility for their health needs.

11/16/2023

I have been seeing this doctor for a long time and service is always great.

11/09/2023

Wonderful care from my Loyola team.

11/09/2023

He is one of the finest Drs I’ve met

10/31/2023

He attentively listened to me and was very supportive and caring

10/20/2023

not at this time, all good.

10/20/2023

I had a pleasant experience. My concerns were addressed.

10/16/2023

Professional

10/16/2023

Exelente

09/28/2023

New Dr

09/27/2023

Great

09/21/2023

I thought all of the individuals we saw were very involved and dedicated to making transplant surgery a success for those that undergo it.

08/30/2023

Will have to wait another 5 weeks for my testing.

08/30/2023

great

07/30/2023

Very professional

07/27/2023

Great team

07/27/2023

Dr. Cotler explains everything clearly.

07/25/2023

It was really good

07/07/2023

The physician was very informative

07/05/2023

Thank you very much for your help, care, and guidance.

06/30/2023

Feel they answer all of my questions!
Show more

Publications

  • Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice. Duehren, S.; Uchida, T.; Tsuge, M.; Hiraga, N.; Uprichard, S. L.; Etzion, O.; Glenn, J.; Koh, C.; Heller, T.; Cotler, S. J.; Oka, S.; Chayama, K.; Dahari, H.; Virus research
  • Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations. Shekhtman, L.; Cotler, S. J.; Degasperi, E.; Anolli, M. P.; Uceda Renteria, S. C.; Sambarino, D.; Borghi, M.; Perbellini, R.; Facchetti, F.; Ceriotti, F.; Lampertico, P.; Dahari, H.; JHEP reports : innovation in hepatology
  • Locoregional Therapies for Hepatocellular Carcinoma prior to Liver Transplant: Comparative Pathologic Necrosis, Radiologic Response, and Recurrence. Mosenthal, M.; Adams, W.; Cotler, S.; Ding, X.; Borge, M.; Malamis, A.; Lee, D.; Thomas, T.; Jawahar, A.; Amin, P.; Molvar, C.; Journal of vascular and interventional radiology : JVIR
  • SBRT vs. Y90: HCC Treatment Outcomes and Costs. deBettencourt, M. F.; Liu, Y.; Cotler, S. J.; Molvar, C. A.; Abdelrahman, T.; Thomas, T. O.; American journal of clinical oncology
  • Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments. Shekhtman, L.; Duehren, S.; Etzion, O.; Cotler, S. J.; Dahari, H.; Current gastroenterology reports
  • MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors. Prasad Venkatesulu, B.; Ness, E.; Ross, D.; Saripalli, A. L.; Abood, G.; Badami, A.; Cotler, S.; Dhanarajan, A.; Knab, L. M.; Lee, B.; Molvar, C.; Sethi, A.; Small, W.; Refaat, T.; American journal of clinical oncology
  • A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion. Elkady, D.; Okorie, C. L.; Estupiñan, B.; Modi, M. B.; Cotler, S. J.; Lake, E.; JAAD case reports
  • Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Malnassy, G.; Keating, C. R.; Gad, S.; Bridgeman, B.; Perera, A.; Hou, W.; Cotler, S. J.; Ding, X.; Choudhry, M.; Sun, Z.; Koleske, A. J.; Qiu, W.; Cellular and molecular gastroenterology and hepatology
  • Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cure. Hershkovich, L.; Shekhtman, L.; Bazinet, M.; Pântea, V.; Placinta, G.; Cotler, S. J.; Vaillant, A.; Dahari, H.; Hepatology communications
  • Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial. Etzion, O.; Hamid, S.; Lurie, Y.; Gane, E. J.; Yardeni, D.; Duehren, S.; Bader, N.; Nevo-Shor, A.; Channa, S. M.; Cotler, S. J.; Mawani, M.; Parkash, O.; Dahari, H.; Choong, I.; Glenn, J. S.; Hepatology (Baltimore, Md.)
  • Modeling-Based Response-Guided Hepatitis C Treatment During Pregnancy and Postpartum. Kushner, T.; Nyabanga, C. T.; Cotler, S. J.; Etzion, O.; Dahari, H.; Open forum infectious diseases
  • Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients. Mhlanga, A.; Zakh, R.; Churkin, A.; Reinharz, V.; Glenn, J. S.; Etzion, O.; Cotler, S. J.; Yurdaydin, C.; Barash, D.; Dahari, H.; Mathematics (Basel, Switzerland)
  • Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration. Goyal, A.; Churkin, A.; Barash, D.; Cotler, S. J.; Shlomai, A.; Etzion, O.; Dahari, H.; Open forum infectious diseases
  • Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. Tatara, E.; Gutfraind, A.; Collier, N. T.; Echevarria, D.; Cotler, S. J.; Major, M. E.; Ozik, J.; Dahari, H.; Boodram, B.; PloS one
  • Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. Hou, W.; Bridgeman, B.; Malnassy, G.; Ding, X.; Cotler, S. J.; Dhanarajan, A.; Qiu, W.; Hepatology communications
  • Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation. Shekhtman, L.; Cotler, S. J.; Ploss, A.; Dahari, H.; Journal of hepatology
  • Machine learning for mathematical models of HCV kinetics during antiviral therapy. Churkin, A.; Kriss, S.; Uziel, A.; Goyal, A.; Zakh, R.; Cotler, S. J.; Etzion, O.; Shlomai, A.; Rotstein, H. G.; Dahari, H.; Barash, D.; Mathematical biosciences
  • Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance. Shekhtman, L.; Navasa, M.; Sansone, N.; Crespo, G.; Subramanya, G.; Chung, T. L.; Cardozo-Ojeda, E. F.; Pérez-Del-Pulgar, S.; Perelson, A. S.; Cotler, S. J.; Forns, X.; Uprichard, S. L.; Dahari, H.; eLife
  • Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos. Missikpode, C.; Kramer, H.; Cotler, S. J.; Durazo-Arvizu, R.; Lash, J. P.; Kallwitz, E.; Cai, J.; Kuniholm, M. H.; Rosas, S. E.; Ricardo, A. C.; Talavera, G. A.; Raij, L.; Pirzada, A.; Daviglus, M. L.; BMC nephrology
  • Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma. Singh, J.; Wozniak, A.; Cotler, S. J.; Dhanarajan, A.; Aldrich, D.; Park, D.; Kasia, C.; Schmidt, B.; Scaglione, S.; Journal of clinical gastroenterology
  • Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling. Wang, H.; Hou, W.; Perera, A.; Bettler, C.; Beach, J. R.; Ding, X.; Li, J.; Denning, M. F.; Dhanarajan, A.; Cotler, S. J.; Joyce, C.; Yin, J.; Ahmed, F.; Roberts, L. R.; Qiu, W.; Cell reports
  • Association of liver enzymes with incident diabetes in US Hispanic/Latino adults. Hua, S.; Qi, Q.; Kizer, J. R.; Williams-Nguyen, J.; Strickler, H. D.; Thyagarajan, B.; Daviglus, M.; Talavera, G. A.; Schneiderman, N.; Cotler, S. J.; Cai, J.; Kaplan, R.; Isasi, C. R.; Diabetic medicine : a journal of the British Diabetic Association
  • Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed. Dahari, H.; Shlomai, A.; Cotler, S. J.; Journal of viral hepatitis
  • A Mathematical Model for early HBV and -HDV Kinetics during Anti-HDV Treatment. Zakh, R.; Churkin, A.; Bietsch, W.; Lachiany, M.; Cotler, S. J.; Ploss, A.; Dahari, H.; Barash, D.; Mathematics (Basel, Switzerland)
  • Letter to the Editor: Examining HBV-RNA Kinetics During NA Treatment-Are NAs Multifunctional Antiviral Agents? Dahari, H.; Vaillant, A.; Cotler, S. J.; Hepatology (Baltimore, Md.)
  • Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Etzion, O.; Dahari, H.; Yardeni, D.; Issachar, A.; Nevo-Shor, A.; Cohen-Naftaly, M.; Ashur, Y.; Uprichard, S. L.; Arbib, O. S.; Munteanu, D.; Braun, M.; Cotler, S. J.; Abufreha, N.; Keren-Naus, A.; Shemer-Avni, Y.; Mor, O.; Murad, J.; Novack, V.; Shlomai, A.; Scientific reports
  • MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS. Tatara, E.; Collier, N. T.; Ozik, J.; Gutfraind, A.; Cotler, S. J.; Dahari, H.; Major, M.; Boodram, B.; Proceedings of the ... Winter Simulation Conference. Winter Simulation Conference
  • Modeling based response guided therapy in subjects with recent hepatitis C infection. Gorstein, E.; Martinello, M.; Churkin, A.; Dasgupta, S.; Walsh, K.; Applegate, T. L.; Yardeni, D.; Etzion, O.; Uprichard, S. L.; Barash, D.; Cotler, S. J.; Matthews, G. V.; Dahari, H.; Antiviral research
  • Finding the Right Balance for the Use of Donation After Circulatory Death Livers for Patients With Hepatocellular Carcinoma. Lee, D. D.; Cotler, S. J.; Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. Li, J.; Hua, S.; Chen, G. C.; Strizich, G.; Kuniholm, M. H.; Shan, Z.; Talavera, G. A.; Castañeda, S. F.; Gellman, M. D.; Cai, J.; Cotler, S. J.; Zhang, X.; Hu, F. B.; Kaplan, R.; Isasi, C. R.; Qi, Q.; Liver international : official journal of the International Association for the Study of the Liver
  • Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. Shekhtman, L.; Cotler, S. J.; Hershkovich, L.; Uprichard, S. L.; Bazinet, M.; Pantea, V.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Krawczyk, A.; Dittmer, U.; Vaillant, A.; Dahari, H.; Scientific reports
  • Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment Duration. Dasgupta, S.; Imamura, M.; Gorstein, E.; Nakahara, T.; Tsuge, M.; Churkin, A.; Yardeni, D.; Etzion, O.; Uprichard, S. L.; Barash, D.; Cotler, S. J.; Dahari, H.; Chayama, K.; The Journal of infectious diseases
  • ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice. Wang, F.; Hou, W.; Chitsike, L.; Xu, Y.; Bettler, C.; Perera, A.; Bank, T.; Cotler, S. J.; Dhanarajan, A.; Denning, M. F.; Ding, X.; Breslin, P.; Qiang, W.; Li, J.; Koleske, A. J.; Qiu, W.; Gastroenterology
  • Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos. Kallwitz, E.; Tayo, B. O.; Kuniholm, M. H.; Daviglus, M.; Zeng, D.; Isasi, C. R.; Cotler, S. J.; Liver international : official journal of the International Association for the Study of the Liver
  • Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Lhomme, S.; DebRoy, S.; Kamar, N.; Abravanel, F.; Metsu, D.; Marion, O.; Dimeglio, C.; Cotler, S. J.; Izopet, J.; Dahari, H.; Viruses
  • Focal Adhesion Kinase and β-Catenin Cooperate to Induce Hepatocellular Carcinoma. Shang, N.; Wang, H.; Bank, T.; Perera, A.; Joyce, C.; Kuffel, G.; Zilliox, M. J.; Cotler, S. J.; Ding, X.; Dhanarajan, A.; Breslin, P.; Qiu, W.; Hepatology (Baltimore, Md.)
  • Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic. Malespin, M.; Harris, C.; Kanar, O.; Jackman, K.; Smotherman, C.; Johnston, A.; Ferm, J.; de Melo, S. W.; Scolapio, J. S.; Nelson, D. R.; Cotler, S. J.; Annals of hepatology
  • Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago. Echevarria, D.; Gutfraind, A.; Boodram, B.; Layden, J.; Ozik, J.; Page, K.; Cotler, S. J.; Major, M.; Dahari, H.; Vaccine
  • American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults. Kallwitz, E. R.; Tayo, B. O.; Kuniholm, M. H.; Cai, J.; Daviglus, M.; Cooper, R. S.; Cotler, S. J.; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C. Koh, C.; Dubey, P.; Han, M. A. T.; Walter, P. J.; Garraffo, H. M.; Surana, P.; Southall, N. T.; Borochov, N.; Uprichard, S. L.; Cotler, S. J.; Etzion, O.; Heller, T.; Dahari, H.; Liang, T. J.; Antiviral research
  • Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography. Shteyer, E.; Shekhtman, L.; Zinger, T.; Harari, S.; Gafanovich, I.; Wolf, D.; Ivgi, H.; Barsuk, R.; Dery, I.; Armoni, D.; Rivkin, M.; Pipalia, R.; Cohen Eliav, M.; Skorochod, Y.; Breuer, G. S.; Tur-Kaspa, R.; Weil Wiener, Y.; Stern, A.; Cotler, S. J.; Dahari, H.; Lurie, Y.; PloS one
  • Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Gambato, M.; Canini, L.; Lens, S.; Graw, F.; Perpiñan, E.; Londoño, M. C.; Uprichard, S. L.; Mariño, Z.; Reverter, E.; Bartres, C.; González, P.; Pla, A.; Costa, J.; Burra, P.; Cotler, S. J.; Forns, X.; Dahari, H.; Liver international : official journal of the International Association for the Study of the Liver
  • Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Major, M.; Gutfraind, A.; Shekhtman, L.; Cui, Q.; Kachko, A.; Cotler, S. J.; Hajarizadeh, B.; Sacks-Davis, R.; Page, K.; Boodram, B.; Dahari, H.; Science translational medicine
  • Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Wang, F.; Bank, T.; Malnassy, G.; Arteaga, M.; Shang, N.; Dalheim, A.; Ding, X.; Cotler, S. J.; Denning, M. F.; Nishimura, M. I.; Breslin, P.; Qiu, W.; Hepatology communications
  • Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis. Loy, V. M.; Joyce, C.; Bello, S.; VonRoenn, N.; Cotler, S. J.; Clinical transplantation
  • Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. Canini, L.; Koh, C.; Cotler, S. J.; Uprichard, S. L.; Winters, M. A.; Han, M. A. T.; Kleiner, D. E.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T.; Dahari, H.; Hepatology communications
  • Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans. Khan, M. W.; Ding, X.; Cotler, S. J.; Clarke, M.; Layden, B. T.; The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients. Canini, L.; Imamura, M.; Kawakami, Y.; Uprichard, S. L.; Cotler, S. J.; Dahari, H.; Chayama, K.; PloS one
  • Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth). Parrinello, C. M.; Rudolph, B. J.; Lazo, M.; Gallo, L. C.; Thyagarajan, B.; Cotler, S. J.; Qi, Q.; Seeherunvong, T.; Vidot, D. C.; Strickler, H. D.; Kaplan, R. C.; Isasi, C. R.; Journal of clinical gastroenterology
  • Modeling HCV cure after an ultra-short duration of therapy with direct acting agents. Goyal, A.; Lurie, Y.; Meissner, E. G.; Major, M.; Sansone, N.; Uprichard, S. L.; Cotler, S. J.; Dahari, H.; Antiviral research
  • End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals. Shteyer, E.; Dahari, H.; Gafanovich, I.; Dery, I.; Wolf, D.; Cotler, S. J.; Lurie, Y.; Therapeutic advances in gastroenterology
  • Adverse Effect of Post-Discharge Care Fragmentation on Outcomes after Readmissions after Liver Transplantation. Kothari, A. N.; Loy, V. M.; Brownlee, S. A.; Ezure, Y.; Schaidle-Blackburn, C.; Cotler, S. J.; di Sabato, D.; Kuo, P. C.; Lu, A. D.; Journal of the American College of Surgeons
  • Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database. Scaglione, S. J.; Metcalfe, L.; Kliethermes, S.; Vasilyev, I.; Tsang, R.; Caines, A.; Mumtaz, S.; Goyal, V.; Khalid, A.; Shoham, D.; Markossian, T.; Luke, A.; Underwood, H.; Cotler, S. J.; Journal of clinical gastroenterology
  • Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation? Raffield, L. M.; Louie, T.; Sofer, T.; Jain, D.; Ipp, E.; Taylor, K. D.; Papanicolaou, G. J.; Avilés-Santa, L.; Lange, L. A.; Laurie, C. C.; Conomos, M. P.; Thornton, T. A.; Chen, Y. I.; Qi, Q.; Cotler, S.; Thyagarajan, B.; Schneiderman, N.; Rotter, J. I.; Reiner, A. P.; Lin, H. J.; Human molecular genetics
  • Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies. Malespin, M.; Benyashvili, T.; Uprichard, S. L.; Perelson, A. S.; Dahari, H.; Cotler, S. J.; Therapeutic advances in gastroenterology
  • Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago. Dam, L.; Cheng, A.; Tran, P.; Wong, S. S.; Hershow, R.; Cotler, S.; Cotler, S. J.; Canadian journal of gastroenterology & hepatology
  • The time and cost investment required to obtain and initiate direct-acting antiviral therapy. Loy, V.; Benyashvili, T.; Adams, W.; Pavkov, D.; O'Mahoney, M.; Cotler, S. J.; Antiviral therapy
  • Resurrection of response-guided therapy for sofosbuvir combination therapies. Dahari, H.; Halfon, P.; Cotler, S. J.; Journal of hepatology
  • An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values. Kliethermes, S.; Ma, M.; Purtell, C.; Balasubramanian, N.; Gonzalez, B.; Layden, T. J.; Cotler, S. J.; Pediatric obesity
  • FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma. Shang, N.; Arteaga, M.; Zaidi, A.; Cotler, S. J.; Breslin, P.; Ding, X.; Kuo, P.; Nishimura, M.; Zhang, J.; Qiu, W.; Gene expression
  • Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer. Kataria, Y.; Deaton, R. J.; Enk, E.; Jin, M.; Petrauskaite, M.; Dong, L.; Goldenberg, J. R.; Cotler, S. J.; Jensen, D. M.; van Breemen, R. B.; Gann, P. H.; BMC gastroenterology
  • HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir. Dahari, H.; Canini, L.; Graw, F.; Uprichard, S. L.; Araújo, E. S.; Penaranda, G.; Coquet, E.; Chiche, L.; Riso, A.; Renou, C.; Bourliere, M.; Cotler, S. J.; Halfon, P.; Journal of hepatology
  • Cure prevents more than transmission of hepatitis C virus. Dahari, H.; Cotler, S. J.; Feld, J. J.; Hepatology (Baltimore, Md.)
  • Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C. Duarte-Rojo, A.; Fischer, S. E.; Adeyi, O.; Zita, D.; Deneke, M. G.; Selzner, N.; Chen, L.; Malespin, M.; Cotler, S. J.; McGilvray, I. D.; Feld, J. J.; Journal of viral hepatitis
  • The distribution of hepatitis B virus exposure and infection in a population-based sample of U.S. Hispanic adults. Jung, M.; Kuniholm, M. H.; Ho, G. Y.; Cotler, S.; Strickler, H. D.; Thyagarajan, B.; Youngblood, M.; Kaplan, R. C.; Del Amo, J.; Hepatology (Baltimore, Md.)
  • Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago. Echevarria, D.; Gutfraind, A.; Boodram, B.; Major, M.; Del Valle, S.; Cotler, S. J.; Dahari, H.; PloS one
  • Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Koh, C.; Canini, L.; Dahari, H.; Zhao, X.; Uprichard, S. L.; Haynes-Williams, V.; Winters, M. A.; Subramanya, G.; Cooper, S. L.; Pinto, P.; Wolff, E. F.; Bishop, R.; Ai Thanda Han, M.; Cotler, S. J.; Kleiner, D. E.; Keskin, O.; Idilman, R.; Yurdaydin, C.; Glenn, J. S.; Heller, T.; The Lancet. Infectious diseases
  • Reply: To PMID 25098971. Guedj, J.; Canini, L.; Cotler, S.; Dahari, H.; Hepatology (Baltimore, Md.)
  • Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kinetics. Dahari, H.; Shteingart, S.; Gafanovich, I.; Cotler, S. J.; D'Amato, M.; Pohl, R. T.; Weiss, G.; Ashkenazi, Y. J.; Tichler, T.; Goldin, E.; Lurie, Y.; Liver international : official journal of the International Association for the Study of the Liver
  • Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Kallwitz, E. R.; Daviglus, M. L.; Allison, M. A.; Emory, K. T.; Zhao, L.; Kuniholm, M. H.; Chen, J.; Gouskova, N.; Pirzada, A.; Talavera, G. A.; Youngblood, M. E.; Cotler, S. J.; Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis. Shang, N.; Arteaga, M.; Zaidi, A.; Stauffer, J.; Cotler, S. J.; Zeleznik-Le, N. J.; Zhang, J.; Qiu, W.; Hepatology (Baltimore, Md.)
  • Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patients. Casadaban, L.; Malespin, M.; Cheung, A.; McGuffey, R. A.; Boulay, B. R.; Halline, A. G.; Brown, R. D.; Cotler, S. J.; Jeon, H.; Bui, J. T.; Gaba, R. C.; Transplantation proceedings
  • Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C. Layden, J. E.; Tayo, B. O.; Cotler, S. J.; Clark, N. M.; Baraoidan, K.; Friedman, S. L.; Cooper, R. S.; Transplantation
  • Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. Malespin, M.; Sleesman, B.; Lau, A.; Wong, S. S.; Cotler, S. J.; Journal of clinical gastroenterology
  • Individualized treatment for patients with low HCV load (genotype 1): a viral kinetic approach. Dahari, H.; Cotler, S. J.; Hepatology (Baltimore, Md.)
  • Biomechanics and functionality of hepatocytes in liver cirrhosis. Sun, S.; Song, Z.; Cotler, S. J.; Cho, M.; Journal of biomechanics
  • Physical activity and metabolic syndrome in liver transplant recipients. Kallwitz, E. R.; Loy, V.; Mettu, P.; Von Roenn, N.; Berkes, J.; Cotler, S. J.; Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society